Patellofemoral Pain Syndrome, Anterior Knee Pain Syndrome
Conditions
Keywords
Blood Flow Restriction, Patellofemoral Pain Syndrome, Physical Therapy, Non-Specific Anterior Knee Pain
Brief summary
The purpose of this study is to determine if Blood Flow Restriction therapy improves patient related outcomes in those diagnosed with Patellofemoral Pain Syndrome compared to those in the sham comparator control group.
Detailed description
Patellofemoral Pain Syndrome (PFPS), also known as Non-Specific Anterior Knee Pain (AKP), is a non-specific musculoskeletal condition characterized by loss of function and pain localized to the patella. PFPS affects up to 22% of the general population yearly, with females affected more so than males. Adolescents (28%, mixed gender) and elite athletes (up to 35% in knee dominant sports such as cycling) are also commonly affected, making this a relatively widespread condition. Additionally, PFPS has a generally unfavorable prognosis, with up to 40% of individuals failing conservative treatment after 1 year, and 57% reporting continued symptoms for 5 to 8-years following. Higher levels of baseline disability and longer duration of symptoms lead to an even poorer prognosis, making early recognition and novel treatments key. To complicate things further, the presence of negative psychosocial factors is commonly found in this population and may be a greater predictor of outcomes than physical ones. Previously, biomechanical factors, such as maltracking of the patella and chondromalacia, have been called into question as potential causes of PFPS symptoms. However, both are now thought to be potential consequences of having PFPS. That being said, PFPS is generally accepted as a non-specific condition as there may be a number of different structures implicated as potential nociceptive drivers, and determining the exact tissue does not seem to be important to overall management strategies. This finding, in connection with the high prevalence of negative psychosocial factors, points less to a physiologically driven condition, and more towards a pain driven condition. While this theoretically makes diagnosing and treatment selection more ubiquitous, there does not seem to be a clear treatment strategy that works best for all patients. Despite a clear biomechanical cause, adjusting exercise selection or technique to include different loads and forces on the patella is still warranted based on patient presentation. For example, during open chain knee extension, the lowest loads are placed on the patella between 90- and 45-degree flexion, and open chain between 0 and 60 degrees. People with PFPS often benefit from adjusting the exercise selection, technique and load. Recent research compared multiple different exercise strategies (combined core and hip work, knee work only, and open vs closed-chain), without any one program showing significant advantage over the others. A combination of these approaches may be best. One theme within PFPS exercise research that appears consistent is the high level of sensitivity and poor response to treatment where higher levels of pain are present. This is in contrast to tendon related pain, such as patellar tendinopathy, where working into moderate levels of pain seems to be helpful for outcomes. The main mechanism driving improvements following exercise therapy for PFPS is not hypertrophy, but rather thought to be exercise induced hypoalgesia. This is a phenomenon where performing both acute bouts, as well as regular exercise (aerobic and resistance), reduces pain both in the short and long terms. Since exercise seems to reduce pain in both local and distant sites of the exercising area, it is thought to provide both local and systemic pain reducing effects. The magnitude and duration of the exercise seems to play an important role as well, with higher intensity and longer durations of exercising producing greater effects. Since patients with PFPS are unable to achieve these desired parameters, alternative strategies need to be investigated. Two options may be blood flow restriction (BFR) therapy and low load training to failure, both of which may capture some of the hypoalgesic effects while minimizing AKP. BFR involves the application of an external device to reduce arterial blood flow to the exercising area, while largely occluding venous return from that same area. Exercise intensities generally range from 20-30% of the patients' 1 repetition maximum (1RM) weight, with relatively high repetitions (sometimes to failure); this is opposed to traditional resistance training at 70%+ of 1RM. BFR training has been demonstrated to amplify the effects of exercise induced hypoalgesia (in addition to a host of other physiological benefits) through unconfirmed mechanisms. Leading theories suggest that the lack of available oxygen to the exercising area may lead to: the activation of the endogenous opioid and cannabinoid systems; systemic changes to the cardiovascular system; or increased number of metabolites such as hydrogen ions and lactic acid, which may also be contributing factors. Clinical research on the application of BFR in patients with PFPS has been both limited and mixed, with only two trials having been conducted in this area. One study from 2017 looked at high-load with BFR placebo, versus low-load BFR with leg press and knee extensions. Only the high-load group showed a modest medium-term effect on pain, lowering it for \ 24 hours after BFR over the training period. The other paper from 2022 included both knee and hip strengthening exercises, comparing a low-load BFR group versus a high-load training group with no placebo; of note, the programs were not equated in terms of exercises completed. In this study, no significant difference was observed between groups. To date, there have been limited to no sham arms in studies where a BFR cuff was used. Given the potential for placebo effects, this was an important consideration in the design of the study. Given the heterogeneity of these two studies, and the paucity of research in this area, the aim of the current study is to compare a low load training to failure (with BFR placebo) to low load BFR training to failure on the effect of pain related outcomes, function, strength and other measures. We hypothesize that BFR training will improve objective and subjective outcomes in patients with patellofemoral pain syndrome (PFPS) more than standard therapy with a sham BFR cuff. Research aim 1: Determine whether the use of BFR improves patient-perceived function through a series of subjective patient-reported outcome measurements (PROs) throughout long-term recovery compared to patients in the sham control group. While we anticipate both groups may show improvement over time, we hypothesize that patients using BFR and the prescribed physical therapy protocol will demonstrate significantly improved PRO scores compared to the sham control group. These PROs include the Lower Extremity Functional Scale (LEFS), Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain (KOOS-PF), the Single Assessment Numerical Evaluation (SANE), the Fear Avoidance Beliefs Questionnaire (FABQ), and Numerical Rating Scale (NRS) Pain Scale 1-10. Participants will be asked to complete PRO at the start of physical therapy (i.e. baseline), 4-weeks, 9-weeks or patient discharge if it is before the scheduled 9-week assessment, 6-month, and 12-month timepoints. Research aim 2: Determine whether the use of BFR improves objective outcome measurements throughout prescribed physical therapy sessions compared to patients in the control group. While we anticipate both groups may show improvement over time, we hypothesize that patients using BFR and the prescribed physical therapy protocol will demonstrate significantly improved quadriceps isometric strength over the sham control group. Outcomes will be measured at the start of the physical therapy (i.e. baseline), 4-weeks, and 9-weeks or patient discharge if it is before the scheduled 9-week assessment.
Interventions
Blood Flow Restriction (BFR) involves the application of an external device to reduce arterial blood flow to the exercising area, while largely occluding venous return from that same area.
PROCEDURESham and standard of Care Therapy
SoC PT + non-inflated BFR cuff
Sponsors
UConn Health
Gaylord Hospital, Inc
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Diagnosis of patellofemoral pain syndrome (PFPS) or non-specific anterior knee pain (NSAKP) and plan to attend Gaylord Specialty Healthcare Physical Therapy
Exclusion criteria
Member of a defined vulnerable population, women who are or suspected to be pregnant, prisoners, children under 15, or other protected populations Body mass of the leg preventing the cuff from fitting properly Radiographic evidence of osteoarthritis (≥ Kellgren-Lawrence Grade 2) History of intra-articular injection into either knee within 3 -months Uncontrolled or untreated inflammatory disorder Acute inflammatory disorder Uncontrolled Diabetes and/or peripheral neuropathy, impaired circulation Uncontrolled cardiac conditions including uncontrolled hypertension Areas of thrombophlebitis, thrombosis Distal wounds or pain below the knee \>4/10 History of or current rhabdomyolysis Prolonged immobilization (\>3 months) Sickle cell anemia Lymphadenectomy Varicose veins, or a history of personal or immediate family history (parental or sibling) of deep vein thrombosis Current infection at or below the level of cuff placement Malignancies in or below the area to be treated Other conditions/medications that would interfere with subject safety or data collection in the opinion of the PI Subjects with an increased risk of non-response as determined by the therapist Once entered in the study, a diagnosis change that affects participation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fear Avoidance Beliefs Questionnaire: 12 Months | This assessment will be collected 12 months post start date. | The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain |
| Fear Avoidance Beliefs Questionnaire: 1 Week | This assessment will be collected 1-week into treatment. | The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain |
| Fear Avoidance Beliefs Questionnaire: 4 Weeks | This assessment will be collected 4-weeks into treatment. | The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain |
| Fear Avoidance Beliefs Questionnaire: 9 Weeks/Discharge | This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first. | The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain |
| Fear Avoidance Beliefs Questionnaire: 6 Months | This assessment will be collected 6 months post start date. | The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain |
| Numeric Pain Rating Scale: Enrollment | This assessment will be collected upon enrollment in the study. | The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours |
| Numeric Pain Rating Scale: 1 Week | This assessment will be collected 1-week into treatment | The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours |
| Numeric Pain Rating Scale: 4 Weeks | This assessment will be collected 4-weeks into treatment. | The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours |
| Numeric Pain Rating Scale: 9 Weeks/Discharge | This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first. | The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours |
| Numeric Pain Rating Scale: 6 Months | This assessment will be collected 6 months post start date. | The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours |
| Numeric Pain Rating Scale: 12 Months | This assessment will be collected 12 months post start date. | The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours |
| Lower Extremity Functional Scale: Enrollment | This assessment will be collected upon enrollment in the study. | The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome |
| Lower Extremity Functional Scale: 1 Week | This assessment will be collected 1-week into treatment. | The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome |
| Lower Extremity Functional Scale: 4 Weeks | This assessment will be collected 4-weeks into treatment. | The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome |
| Lower Extremity Functional Scale: 9 Weeks/Discharge | This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first. | The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome |
| Lower Extremity Functional Scale: 6 Months | This assessment will be collected 6 months post start date. | The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome |
| Lower Extremity Functional Scale: 12 Months | This assessment will be collected 12 months post start date. | The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome |
| Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: Enrollment | This assessment will be collected upon enrollment in the study. | The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms |
| Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 1 Week | This assessment will be collected1-week into treatment. | The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms |
| Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 4 Weeks | This assessment will be collected 4-weeks into treatment. | The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms |
| Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 9 Weeks/Discharge | This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first. | The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms |
| Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 6 Months | This assessment will be collected 6 months post start date. | The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms |
| Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 12 Months | This assessment will be collected 12 months post start date. | The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms |
| Single Assessment Numerical Evaluation: Enrollment | This assessment will be collected upon enrollment in the study. | The SANE is a two item questionnaire used globally to assess function |
| Single Assessment Numerical Evaluation: 1 Week | This assessment will be collected 1-week into treatment. | The SANE is a two item questionnaire used globally to assess function |
| Single Assessment Numerical Evaluation: 4 Weeks | This assessment will be collected 4-weeks into treatment. | The SANE is a two item questionnaire used globally to assess function |
| Single Assessment Numerical Evaluation: 9 Weeks/Discharge | This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first. | The SANE is a two item questionnaire used globally to assess function |
| Single Assessment Numerical Evaluation: 6 Months | This assessment will be collected 6 months post start date. | The SANE is a two item questionnaire used globally to assess function |
| Single Assessment Numerical Evaluation: 12 Months | This assessment will be collected 12 months post start date. | The SANE is a two item questionnaire used globally to assess function |
| Tenger Activity Scale: Enrollment | This assessment will be collected upon enrollment. | The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale. |
| Tenger Activity Scale: 6 Months | This assessment will be collected 6 months post start date. | The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale. |
| Tenger Activity Scale: 12 Months | This assessment will be collected 12 months post start date. | The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale. |
| Fear Avoidance Beliefs Questionnaire: Enrollment | This assessment will be collected upon enrollment in the study. | The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Quadricep Isometric Strength: 1 Week | This assessment will be collected 1-week into treatment. | Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry |
| Quadricep Isometric Strength: 4 Weeks | This assessment will be collected 4-weeks into treatment. | Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry |
| Quadricep Isometric Strength: 9 Weeks/Discharge | This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first. | Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry |
| Quadricep Isometric Strength: Enrollment | This assessment will be collected upon enrollment in the study. | Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Blood Flow Restriction and Standard of Care Therapy The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength.
Blood Flow Restriction Cuff: Blood Flow Restriction (BFR) involves the application of an external device to reduce arterial blood flow to the exercising area, while largely occluding venous return from that same area. | 0 |
| Sham and Standard of Care Therapy The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases.
Sham and standard of Care Therapy: SoC PT + non-inflated BFR cuff | 0 |
| Total | 0 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Withdrawal by Subject | 1 | 0 |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Primary
Fear Avoidance Beliefs Questionnaire: 12 Months
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time frame: This assessment will be collected 12 months post start date.
Population: Study terminated and participant withdrawal
Primary
Fear Avoidance Beliefs Questionnaire: 1 Week
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time frame: This assessment will be collected 1-week into treatment.
Population: Study terminated and participant withdrawal
Primary
Fear Avoidance Beliefs Questionnaire: 4 Weeks
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time frame: This assessment will be collected 4-weeks into treatment.
Population: Study terminated and participant withdrawal
Primary
Fear Avoidance Beliefs Questionnaire: 6 Months
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time frame: This assessment will be collected 6 months post start date.
Population: Study terminated and participant withdrawal
Primary
Fear Avoidance Beliefs Questionnaire: 9 Weeks/Discharge
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time frame: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Population: Study terminated and participant withdrawal
Primary
Fear Avoidance Beliefs Questionnaire: Enrollment
The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain
Time frame: This assessment will be collected upon enrollment in the study.
Population: Study terminated and participant withdrawal
Primary
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 12 Months
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time frame: This assessment will be collected 12 months post start date.
Population: Study terminated and participant withdrawal
Primary
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 1 Week
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time frame: This assessment will be collected1-week into treatment.
Population: Study terminated and participant withdrawal
Primary
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 4 Weeks
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time frame: This assessment will be collected 4-weeks into treatment.
Population: Study terminated and participant withdrawal
Primary
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 6 Months
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time frame: This assessment will be collected 6 months post start date.
Population: Study terminated and participant withdrawal
Primary
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: 9 Weeks/Discharge
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time frame: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Population: Study terminated and participant withdrawal
Primary
Knee Injury and Osteoarthritis Outcome Score for Patellofemoral Pain: Enrollment
The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms
Time frame: This assessment will be collected upon enrollment in the study.
Population: Study terminated and participant withdrawal
Primary
Lower Extremity Functional Scale: 12 Months
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time frame: This assessment will be collected 12 months post start date.
Population: Study terminated and participant withdrawal
Primary
Lower Extremity Functional Scale: 1 Week
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time frame: This assessment will be collected 1-week into treatment.
Population: Study terminated and participant withdrawal
Primary
Lower Extremity Functional Scale: 4 Weeks
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time frame: This assessment will be collected 4-weeks into treatment.
Population: Study terminated and participant withdrawal
Primary
Lower Extremity Functional Scale: 6 Months
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time frame: This assessment will be collected 6 months post start date.
Population: Study terminated and participant withdrawal
Primary
Lower Extremity Functional Scale: 9 Weeks/Discharge
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time frame: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Population: Study terminated and participant withdrawal
Primary
Lower Extremity Functional Scale: Enrollment
The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome
Time frame: This assessment will be collected upon enrollment in the study.
Population: Study terminated and participant withdrawal
Primary
Numeric Pain Rating Scale: 12 Months
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time frame: This assessment will be collected 12 months post start date.
Population: Study terminated and participant withdrawal
Primary
Numeric Pain Rating Scale: 1 Week
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time frame: This assessment will be collected 1-week into treatment
Population: Study terminated and participant withdrawal
Primary
Numeric Pain Rating Scale: 4 Weeks
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time frame: This assessment will be collected 4-weeks into treatment.
Population: Study terminated and participant withdrawal
Primary
Numeric Pain Rating Scale: 6 Months
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time frame: This assessment will be collected 6 months post start date.
Population: Study terminated and participant withdrawal
Primary
Numeric Pain Rating Scale: 9 Weeks/Discharge
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time frame: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Population: Study terminated and participant withdrawal
Primary
Numeric Pain Rating Scale: Enrollment
The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours
Time frame: This assessment will be collected upon enrollment in the study.
Population: Study terminated and participant withdrawal
Primary
Single Assessment Numerical Evaluation: 12 Months
The SANE is a two item questionnaire used globally to assess function
Time frame: This assessment will be collected 12 months post start date.
Population: Study terminated and participant withdrawal
Primary
Single Assessment Numerical Evaluation: 1 Week
The SANE is a two item questionnaire used globally to assess function
Time frame: This assessment will be collected 1-week into treatment.
Population: Study terminated and participant withdrawal
Primary
Single Assessment Numerical Evaluation: 4 Weeks
The SANE is a two item questionnaire used globally to assess function
Time frame: This assessment will be collected 4-weeks into treatment.
Population: Study terminated and participant withdrawal
Primary
Single Assessment Numerical Evaluation: 6 Months
The SANE is a two item questionnaire used globally to assess function
Time frame: This assessment will be collected 6 months post start date.
Population: Study terminated and participant withdrawal
Primary
Single Assessment Numerical Evaluation: 9 Weeks/Discharge
The SANE is a two item questionnaire used globally to assess function
Time frame: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Population: Study terminated and participant withdrawal
Primary
Single Assessment Numerical Evaluation: Enrollment
The SANE is a two item questionnaire used globally to assess function
Time frame: This assessment will be collected upon enrollment in the study.
Population: Study terminated and participant withdrawal
Primary
Tenger Activity Scale: 12 Months
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Time frame: This assessment will be collected 12 months post start date.
Population: Study terminated and participant withdrawal
Primary
Tenger Activity Scale: 6 Months
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Time frame: This assessment will be collected 6 months post start date.
Population: Study terminated and participant withdrawal
Primary
Tenger Activity Scale: Enrollment
The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.
Time frame: This assessment will be collected upon enrollment.
Population: Study terminated and participant withdrawal
Secondary
Quadricep Isometric Strength: 1 Week
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time frame: This assessment will be collected 1-week into treatment.
Population: Study terminated and participant withdrawal
Secondary
Quadricep Isometric Strength: 4 Weeks
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time frame: This assessment will be collected 4-weeks into treatment.
Population: Study terminated and participant withdrawal
Secondary
Quadricep Isometric Strength: 9 Weeks/Discharge
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time frame: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.
Population: Study terminated and participant withdrawal
Secondary
Quadricep Isometric Strength: Enrollment
Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry
Time frame: This assessment will be collected upon enrollment in the study.
Population: Study terminated and participant withdrawal